Issued Patents All Time
Showing 51–75 of 152 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11510937 | CFTR MRNA compositions and related methods and uses | Michael Heartlein, Braydon Charles Guild, Carsten Rudolph, Christian Plank, Lianne Smith | 2022-11-29 |
| 11497716 | Lipid-derived neutral nanoparticles | Braydon Charles Guild, Michael Heartlein | 2022-11-15 |
| 11453877 | Methods for purification of messenger RNA | Jonathan Abysalh, Jorel E. Vargas, Cameron M. Smith | 2022-09-27 |
| 11447520 | Ribonucleic acids with 4′-thio-modified nucleotides and related methods | Michael Heartlein | 2022-09-20 |
| 11433144 | Biodegradable lipids for delivery of nucleic acids | Michael Heartlein | 2022-09-06 |
| 11427535 | Polyanionic delivery of nucleic acids | Michael Heartlein, Shrirang Karve | 2022-08-30 |
| 11400109 | Subcutaneous delivery of messenger RNA | Shrirang Karve, Zarna Bhavsar, Michael Heartlein | 2022-08-02 |
| 11377642 | mRNA therapy for phenylketonuria | Michael Heartlein, Anusha Dias | 2022-07-05 |
| 11365437 | Quantitative assessment for cap efficiency of messenger RNA | Michael Heartlein, Anusha Dias | 2022-06-21 |
| 11357726 | Process of preparing mRNA-loaded lipid nanoparticles | Shrirang Karve, Zarna Patel, Yi Zhang, Ashish Sarode, Rebecca L. Goldman +1 more | 2022-06-14 |
| 11338044 | Lipid nanoparticle compositions and methods for mRNA delivery | Braydon Charles Guild, Michael Heartlein | 2022-05-24 |
| 11291734 | Lipid nanoparticle compositions and methods for mRNA delivery | Braydon Charles Guild, Michael Heartlein | 2022-04-05 |
| 11254936 | Nuclease resistant polynucleotides and uses thereof | Michael Heartlein, Braydon Charles Guild | 2022-02-22 |
| 11253605 | Codon-optimized CFTR MRNA | Anusha Dias, Jonathan Abysalh, Brian Bettencourt, Michael Heartlein | 2022-02-22 |
| 11234936 | Cleavable lipids | Braydon Charles Guild, Michael Heartlein, Jerry Chi Zhang | 2022-02-01 |
| 11224642 | MRNA therapy for argininosuccinate synthetase deficiency | Michael Heartlein, Lianne Smith | 2022-01-18 |
| 11185595 | Lipid nanoparticle compositions and methods for mRNA delivery | Braydon Charles Guild, Michael Heartlein | 2021-11-30 |
| 11174500 | Methods for purification of messenger RNA | Joseph Parella, Kimberly Gillis, Jonathan Abysalh, Travis Jeannotte, Erik Held +2 more | 2021-11-16 |
| 11173190 | Treatment of cystic fibrosis by delivery of codon-optimized mRNA encoding CFTR | Michael Heartlein, Alan Kimura, Jonathan Abysalh, Anusha Dias, Shrirang Karve +1 more | 2021-11-16 |
| 11167043 | Composition and methods for treatment of ornithine transcarbamylase deficiency | Kim Askew, Jou-Ku Chung, Michael Heartlein, Shrirang Karve, Thomas McCauley +2 more | 2021-11-09 |
| 11135274 | MRNA for use in treatment of human genetic diseases | Braydon Charles Guild, Michael Heartlein | 2021-10-05 |
| 11124804 | Multimeric coding nucleic acid and uses thereof | Michael Heartlein, Daniel Crawford, Shrirang Karve | 2021-09-21 |
| 11104934 | Quantitative assessment for cap efficiency of messenger RNA | Michael Heartlein, Anusha Dias | 2021-08-31 |
| 11104652 | Stereochemically enriched compositions for delivery of nucleic acids | Shrirang Karve, Michael Heartlein | 2021-08-31 |
| 11090368 | MRNA therapy for Pompe disease | Michael Heartlein | 2021-08-17 |